MiR-223-3p通过靶向NLRP3对坏死性小肠结肠炎新生大鼠肠组织的炎症反应和细胞损伤的影响

doi:10.11852/zgetbjzz2022-0252

摘要/Abstract

摘要： 目的探究microRNA-223-3p(MiR-223-3p)对坏死性小肠结肠炎(NEC)新生大鼠肠组织的炎症反应和细胞损伤的影响及可能的机制。方法构建新生大鼠NEC模型,随机分为NEC组、阴性对照组、MiR-223-3p过表达组,每组20只。另取相同数量正常大鼠作为正常组。苏木精-伊红(HE)染色、TUNEL染色检测肠组织病理学变化和细胞凋亡情况;ELISA法检测血清和肠组织中白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)和白细胞介素-18(IL-18)水平;SYBR Green I实时荧光定量PCR法检测肠组织中MiR-223-3p表达;Western Blot检测肠组织中NLRP3和caspase-1蛋白表达情况。双荧光素酶报告基因实验验证MiR-223-3p与NLRP3是否存在靶向关系。结果与正常组比较,NEC组和阴性对照组大鼠血清及肠组织中IL-6、IL-1β、IL-18含量明显升高(F=215.525、276.499、354.826、204.410、261.474、280.667,P＜0.05),肠组织中NLRP3和caspase-1蛋白表达及细胞凋亡率均明显升高(F=181.745、137.553,P＜0.05),肠组织中MiR-223-3p表达明显降低(F=170.180,P＜0.05),且肠组织存在明显病理学损伤。与阴性对照组比较,MiR-223-3p过表达组能够上调肠组织中MiR-223-3p表达,降低大鼠血清及肠组织中IL-6、IL-1β、IL-18含量及细胞凋亡率,抑制NLRP3和caspase-1蛋白表达(P＜0.05),且肠组织病理学损伤明显改善。双荧光素酶报告基因实验分析结果显示,MiR-223-3p与NLRP3能够靶向结合。结论 MiR-223-3p通过靶向NLRP3减轻NEC新生大鼠肠组织的炎症反应和细胞损伤。

关键词: MiR-223-3p, NLRP3, 坏死性小肠结肠炎, 新生大鼠, 炎症反应, 细胞凋亡

Abstract: Objective To explore the effects of microRNA-223-3p(MiR-223-3p) on the inflammatory response and cell damage in the intestinal tissue of neonatal rats with necrotizing enterocolitis(NEC) and its possible mechanism. Methods The NEC model of neonatal rats was constructed and randomly divided into a model group, a negative control group, and a MiR-223-3p overexpression group. The normal rats of same number were taken as the normal group. Hematoxylin-eosin(HE) staining and TUNEL staining were used to detect intestinal histopathological changes and cell apoptosis; ELISA method was used to detect the levels of interleukin-6(IL-6), interleukin-1β(IL-1β) and interleukin-18(IL-18) in serum and intestinal tissues; SYBR Green Ⅰ real-time fluorescent quantitative PCR method was used to detect the expression of MiR-223-3p in intestinal tissues; Western Blot was used to detect the expression of NLRP3 and caspase-1 proteins in intestinal tissue. Dual luciferase reporter gene experiment was used to verify the target relationship between MiR-223-3p and NLRP3. Results Compared with the normal group, the levels of IL-6, IL-1β, IL-18 in the serum and intestinal tissues of rats in the model group and the negative control group were all significantly increased(F=215.525, 276.499, 354.826, 204.410, 261.474, 280.667, P<0.05), the expression of NLRP3 and caspase-1 proteins in the intestinal tissues and the apoptosis rate were all significantly increased(F=181.745, 137.553, P<0.05), the expression of MiR-223-3p in the intestinal tissue was significantly reduced(F=170.180, P<0.05), and there was obvious pathological damage in the intestinal tissue. Compared with the negative control group, the MiR-223-3p overexpression group was able to up-regulate the expression of MiR-223-3p in intestinal tissues, reduce the levels of IL-6, IL-1β, IL-18 and cell apoptosis in rat serum and intestinal tissues, inhibit the expression of NLRP3 and caspase-1 proteins(P<0.05), and the pathological damage of intestinal tissue was significantly improved. The results of the dual luciferase reporter gene experimental analysis showed that MiR-223-3p and NLRP3 was able to targetingly be combined. Conclusion MiR-223-3p reduces inflammation and cell damage in the intestinal tissue of NEC neonatal rats by targeting NLRP3.

Key words: MiR-223-3p, NLRP3, necrotizing enterocolitis, neonatal rat, inflammatory response, apoptosis

中图分类号:

R725.7

蔡冬, 周丽霞, 许花芬. MiR-223-3p通过靶向NLRP3对坏死性小肠结肠炎新生大鼠肠组织的炎症反应和细胞损伤的影响[J]. 中国儿童保健杂志, 2023, 31(1): 46-51.

CAI Dong, ZHOU Li-xia, XU Hua-fen. The effects of MiR-223-3p on the inflammatory response and cell damage in the intestinal tissue of neonatal rats with necrotizing enterocolitis by targeting NLRP3[J]. Chinese Journal of Child Health Care, 2023, 31(1): 46-51.

参考文献

[1] 中国医师协会新生儿科医师分会循证专业委员会. 新生儿坏死性小肠结肠炎临床诊治指南[J]. 中国当代儿科杂志, 2021, 23(1):1-11.
Evidence Based Specialty Committee of the Division of Neonatologists, Chinese Medical Association. Clinical guidelines for the diagnosis and treatment of neonatal necrotizing enterocolitis(2020)[J]. Chin J Contemp Pediatr, 2021, 23(1):1-11.
[2] Nio DF,Sodhi C,Hackam DJ.Necrotizing enterocolitis:New insights into pathogenesis and mechanisms[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(10):590-600.
[3] Matei A, Montalva L, Goodbaum A, et al. Neurodevelopmental impairment in necrotising enterocolitis survivors:Systematic review and Meta-analysis[J]. Arch Dis Child Fetal Neonatal Ed, 2020, 105(4):432-439.
[4] 陈锐, 赵云, 赵晓霞, 等. 沉默信息调节因子1在新生儿坏死性小肠结肠炎肠组织中的表达特点[J]. 上海交通大学学报(医学版), 2021, 41(9):1141-1161.
Zhao R, Zhao Y, Zhao XX, et al. Expression characteristics of silent information regulator transcript 1 in intestinal tissues of neonatal necrotizingenterocolitis[J].J Shanghai Jiaotong Univ(Med Sci), 2021, 41(9):1141-1161.
[5] 傅洪敏, 任秋月, 常柏, 等. 抵挡汤对糖尿病大血管病变小鼠主动脉NLIRP3炎症小体活化炎症级联反应的作用机制[J]. 中国实验方剂学杂志, 2021, 27(11):1-8.
Fu HM, Ren QY, Chang B, et al. Mechanism of Didangtang in inhibiting aortic NLRP3 inflammasome cascade of mice with diabetic macrovascular disease[J]. Chin J Experim Tradit Med Formulae, 2021, 27(11):1-8.
[6] 刘雪琼, 祝淡抹, 杨燕, 等. miR-223-3p靶向NLRP3调控子痫前期胎盘中炎性反应的机制研究[J]. 现代妇产科进展, 2021, 30(5):335-345.
Liu XQ, Zhu DM, Yang Y, et al. Study on the mechanism of miR-223-3p regulating the inflammatory response in placenta of preeclampsia via targeting NLRP3[J]. Prog Obstet Gynecol, 2021, 30(5):335-345.
[7] 邓沁, 郭春宝. 双歧杆菌对坏死性小肠结肠炎新生小鼠肠组织的保护作用[J]. 解放军医学杂志, 2020, 45(1):49-54.
Deng Q, Guo CB. Protective effect of Bifidobacterium on endothelial nitric oxide synthase in neonatal necrotizing enterocolitis model[J]. Med J Chin PLA, 2020, 45(1):49-54.
[8] 王瑛, 张莹楠, 常新捷, 等. 白藜芦醇调控miR-223对坏死性小肠结肠炎小鼠细胞焦亡的作用机制[J]. 中国药理学通报, 2021, 37(9):1245-1250.
Wang Y, Zhang YN, Chang XJ, et al. Study on mechanism of resveratrol regulating miR-223 on pyroptosis in mice with necrotizing enterocolitis[J]. Chin Pharmacol Bull, 2021, 37(9):1245-1250.
[9] 李娜, 李忠良, 张春雷, 等. 新生儿坏死性小肠结肠炎发病机制的新进展[J]. 中国儿童保健杂志, 2021, 20(9):37-40.
Li N, Li ZL, Zhang CL, et al. New progress in the pathogenesis of neonatal necrotizing enterocolitis[J]. Chin J Child Health Care, 2021, 20(9):37-40.
[10] 王雪, 邹谋, 张绍卿, 等. 坏死性小肠结肠炎对新生小鼠脑损伤及其程度的影响[J]. 第三军医大学学报, 2021, 43(17):1634-1641.
Wang X, Zou M, Zhang SQ, et al. Effects of necrotizing enterocolitis on brain injury and its severity in neonatal mice[J]. Acta Acad Med Mil Tert, 2021, 43(17):1634-1641.
[11] Cho SX, Berger PJ, Nold-petry CA, et al. The immunological landscape in necrotising enterocolitis[J]. Expert Rev Mol Med, 2016, 18(1):12-28.
[12] Cho SX, Rudloff I, Lao JC, et al. Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities[J]. Nat Commun, 2020, 11(1):5794.
[13] Agakidou E, Agakidis C, Gika H, et al. Emerging biomarkers for prediction and early diagnosis of necrotizing enterocolitis in the era of metabolomics and proteomics[J]. Front Pediatr, 2020, 8(1):602255-602271.
[14] 魏秋红, 高欢, 刘晓月, 等. 新型水解蛋清蛋白短肽对大鼠结肠炎症的保护作用[J]. 中国食品学报, 2021, 8(21):121-127.
Wei QH, Gao H, Liu XY, et al. Protective effect of a novel hydrolyzed egg white short polypeptide on colitis in rats[J]. J Chin Inst Food Sci and Technol, 2021, 8(21):121-127.
[15] 龙熙翠, 刘贝贝, 卢邵波, 等. 细胞焦亡因子Caspase-1、IL-1β与IL-18在子宫内膜息肉组织中的表达和意义[J]. 昆明医科大学学报, 2021, 42(9):52-56.
Long XC, Liu BB, Lu SB, et al. The expression and significance of pyroptosis factor cytokine caspase-1、IL-1β and IL-18 in endometrial polys[J]. J Kunming Med Univ, 2021, 42(9):52-56.
[16] 赵铭, 秦苗, 孙梦雅, 等. NLRP3及相关炎性因子在新生大鼠坏死性小肠结肠炎中的表达研究[J]. 中国儿童保健杂志, 2021, 29(8):852-856.
Zhao M, Qin M, Sun MY, et al. Study on the expression of NLRP3 and related inflammatory factors in necrotizing enterocolitis in newborn rats[J]. Chin J Child Health Care, 2021, 29(8):852-856.
[17] Hall JE, DO Carmo JM, Da Silva AA, et al. Obesity, kidney dysfunction and hypertension:Mechanistic links[J]. Nat Rev Nephrol, 2019, 15(6):367-385.
[18] Neudecker V, Haneklaus M, Jensen O, et al. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome[J]. J Exp Med, 2017, 214(6):1737-1752.
[19] Chen LQ, Hou XY, Zhang MM, et al. MicroRNA-223-3p modulates dendritic cell function and ameliorates experimental autoimmune myocarditis by targeting the NLRP3 inflammasome[J]. Mol Immunol, 2020, 117(16):73-83.